Optogenetic-based biosensing uses light-responsive control in engineered cells to support cell-based sensing and real-time cellular diagnostics. The review frames it as a biosensing approach enabled by optogenetics and advanced biomaterials.
First-pass extracted concept
optogenetic-based biosensing
Candidate: concept label1 source documents9 linked claims
Live refresh every 5sNext refresh in 5s
Extracted Explainers
What the tool is doing
Resources required
The abstract indicates that engineered cells, optogenetic control, advanced biomaterials, and analytic platforms are required. It also highlights electro-optical label-free assay formats as part of the approach.
The abstract indicates a need for engineered cells, optogenetic control, and advanced biomaterials or analytic platforms. Specific constructs and hardware are not detailed in the abstract.
What problem it solves
The review states that these biosensors can detect bioactive or toxic analytes faster and with higher sensitivity than classical cellular sensors. It also presents them as a route toward improved standardization.
It is presented as a way to make cell-based biosensors faster, more sensitive, and more standardized. The review especially highlights detection of low concentrations of bioactive or toxic analytes.
What it does not solve
Evidence Snippets
The advancements concerning enabling biomaterials and related novel biosensing concepts involving optogenetics are reviewed
The advancements concerning enabling biomaterials and related novel biosensing concepts involving optogenetics are reviewed with particular focus on the use of engineered cells for cell-based sensing platforms
Supporting Sources
Linked Claims
Multimodal functional electro-optical label-free assays are key elements for optogenetic-based biosensing standardization.
Modified optogenetic cell-based biosensors are described as enabling significantly faster detection, on the order of minutes instead of hours, compared with classical cellular sensors.
Modified optogenetic cell-based biosensors offer faster detection than classical cellular sensors.
Modified optogenetic cell-based biosensors provide higher sensitivity for detecting low concentrations of bioactive or toxic analytes than classical cellular sensors.
The review focuses on engineered-cell sensing platforms, enabling biomaterials, and an optogenetic toolbox spanning actuators, reporters, and multifunctional opto-chemogenetic tools for real-time cellular diagnostics and biosensor development.
This paper reviews enabling biomaterials and novel biosensing concepts involving optogenetics, with emphasis on engineered cell-based sensing platforms and toolboxes for real-time cellular diagnostics and biosensor development.
Modified optogenetic cell-based biosensors are described as having higher sensitivity for detecting low concentrations of bioactive or toxic analytes, including below threshold concentrations for classical cellular sensors.
Unified analytic platforms improve standardization of optogenetic cell-based biosensors.
Unified analytic platforms are described as improving standardization of optogenetic-based cell biosensors.